-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Adma Biologics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Adma Biologics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $35.9M, a 1300% increase year-over-year.
- Adma Biologics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $68.1M.
- Adma Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$28.2M, a 57.2% increase from 2022.
- Adma Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$65.9M, a 8.02% increase from 2021.
- Adma Biologics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$71.6M, a 5.41% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)